ZCMD Key Statistics, Chart & Performance
The current stock price of ZCMD is 0.6461 USD. In the past month the price decreased by -3.58%. In the past year, price decreased by -51.78%.
ZCMD Latest News, Press Relases and Analysis
ZCMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| DUOL | DUOLINGO | 23.91 | 8.63B | ||
| BFAM | BRIGHT HORIZONS FAMILY SOLUT | 23.34 | 5.83B | ||
| GHC | GRAHAM HOLDINGS CO-CLASS B | 17.43 | 4.76B | ||
| LAUR | LAUREATE EDUCATION INC | 22.47 | 4.54B | ||
| LOPE | GRAND CANYON EDUCATION INC | 17.72 | 4.39B | ||
| ATGE | ADTALEM GLOBAL EDUCATION INC | 12.95 | 3.36B | ||
| MH | MCGRAW HILL INC | N/A | 3.27B | ||
| LRN | STRIDE INC | 9.85 | 2.78B | ||
| STRA | STRATEGIC EDUCATION INC | 13.6 | 1.83B | ||
| PRDO | PERDOCEO EDUCATION CORP | 11.09 | 1.80B | ||
| COUR | COURSERA INC | 18.9 | 1.32B | ||
| UTI | UNIVERSAL TECHNICAL INSTITUT | 20.28 | 1.26B |
Related stock screener links
About ZCMD
Company Profile
Zhongchao, Inc. is a holding company, which engages in the provision of healthcare information, education, and training services. The company is headquartered in Shanghai, Shanghai and currently employs 111 full-time employees. The company went IPO on 2020-02-19. The firm operates its businesses through two segments. MDMOOC Services segment engages in the provision of training and education services and assistance in patient-aid projects. Sales of Patented Drugs segment mainly engages in the sales of patented drugs. Under the MDMOOC brand, the Company offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.
Company Info
ZHONGCHAO INC-CLASS A
841 Yan An Middle Road, Jing An District, Nanxi Creative Center, Suite 218
Shanghai SHANGHAI 200040 CN
CEO: Weiguang Yang
Employees: 111
Phone: 862132205987
ZHONGCHAO INC-CLASS A / ZCMD FAQ
What does ZHONGCHAO INC-CLASS A do?
Zhongchao, Inc. is a holding company, which engages in the provision of healthcare information, education, and training services. The company is headquartered in Shanghai, Shanghai and currently employs 111 full-time employees. The company went IPO on 2020-02-19. The firm operates its businesses through two segments. MDMOOC Services segment engages in the provision of training and education services and assistance in patient-aid projects. Sales of Patented Drugs segment mainly engages in the sales of patented drugs. Under the MDMOOC brand, the Company offers a wide range of online and onsite health information services, healthcare education programs, and healthcare training products, consisting primarily of clinical practice training, open classes of medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content to healthcare professionals as well as the public.
Can you provide the latest stock price for ZHONGCHAO INC-CLASS A?
The current stock price of ZCMD is 0.6461 USD. The price increased by 5.06% in the last trading session.
Does ZCMD stock pay dividends?
ZCMD does not pay a dividend.
How is the ChartMill rating for ZHONGCHAO INC-CLASS A?
ZCMD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in ZHONGCHAO INC-CLASS A be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ZCMD.
What is the ownership structure of ZHONGCHAO INC-CLASS A (ZCMD)?
You can find the ownership structure of ZHONGCHAO INC-CLASS A (ZCMD) on the Ownership tab.
ZCMD Technical Analysis
ZCMD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ZCMD. ZCMD has a great financial health rating, but its profitability evaluates not so good.
ZCMD Financial Highlights
Over the last trailing twelve months ZCMD reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 94.72% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.46% | ||
| ROE | -8.38% | ||
| Debt/Equity | 0 |